Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells.
Dehai YuZhonghua DuLingling PianTao LiXue WenWei LiSu-Jeong KimJialin XiaoPinchas CohenJiu-Wei CuiAndrew R HoffmanJi-Fan HuPublished in: Stem cells international (2017)
Background. Fetal heart can regenerate to restore its normal anatomy and function in response to injury, but this regenerative capacity is lost within the first week of postnatal life. Although the specific molecular mechanisms remain to be defined, it is presumed that aging of cardiac stem or progenitor cells may contribute to the loss of regenerative potential. Methods. To study this aging-related dysfunction, we cultured mesenchymal stem cells (MSCs) from human fetal heart tissues. Senescence was induced by exposing cells to chronic oxidative stress/low serum. Mitochondrial DNA methylation was examined during the period of senescence. Results. Senescent MSCs exhibited flattened and enlarged morphology and were positive for the senescence-associated beta-galactosidase (SA-β-Gal). By scanning the entire mitochondrial genome, we found that four CpG islands were hypomethylated in close association with senescence in MSCs. The mitochondrial COX1 gene, which encodes the main subunit of the cytochrome c oxidase complex and contains the differentially methylated CpG island 4, was upregulated in MSCs in parallel with the onset of senescence. Knockdown of DNA methyltransferases (DNMT1, DNMT3a, and DNMT3B) also upregulated COX1 expression and induced cellular senescence in MSCs. Conclusions. This study demonstrates that mitochondrial CpG hypomethylation may serve as a critical biomarker associated with cellular senescence induced by chronic oxidative stress.
Keyphrases
- mesenchymal stem cells
- endothelial cells
- oxidative stress
- dna methylation
- dna damage
- high glucose
- umbilical cord
- diabetic rats
- genome wide
- mitochondrial dna
- induced apoptosis
- stress induced
- copy number
- bone marrow
- gene expression
- cell therapy
- heart failure
- stem cells
- ischemia reperfusion injury
- left ventricular
- high resolution
- clinical trial
- atrial fibrillation
- transcription factor
- preterm infants
- single molecule
- endoplasmic reticulum stress
- circulating tumor